• Home Blog Tag Duchenne muscular dystrophy market

Duchenne Muscular Dystrophy Market

Aug 05, 2025

Anbogen’s ABT-301 Cleared by FDA for Phase I/II Colorectal Cancer Trial; Dyne’s DYNE-251 Gets FDA Breakthrough Tag for Duchenne Muscular Dystrophy; BMS’s BREYANZI Accepted for FDA Priority Review in MZL; Clarametyx’s CMTX-101 Earns FDA Fast Track and QIDP for Infections; Anixa Begins FDA-Approved IND Transfer for Phase II Breast Cancer Vaccine Trial

Aug 23, 2024

What Does the Future Hold for Gene Therapy in the Duchenne Muscular Dystrophy (DMD) Treatment Market?

Aug 20, 2024

In Search for a Curative Treatment Option for Duchenne Muscular Dystrophy

Aug 20, 2024

Duchenne Muscular Dystrophy Market: What’s More Beyond Exon-Skipping Therapies?

Aug 20, 2024

Is the Cure for Duchenne Muscular Dystrophy in the Pipeline?

Jun 19, 2024

Gene therapy: Following Pfizer’s Unexpected Failure, Sarepta is celebrating its much-awaited full approval! Sarepta’s stock price has shot up over 32%

Jun 30, 2023

Sarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment

Newsletter/Whitepaper